These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A standard-controlled clinical study with propericiazine in schizophrenic patients. Ananth JV; Ban TA Psychopharmacol Bull; 1977 Jul; 13(3):19-20. PubMed ID: 18754 [No Abstract] [Full Text] [Related]
4. [Report on clinical trials of a new neuroleptic drug]. Stucke W Med Welt; 1969 Feb; 7():356-9. PubMed ID: 5801526 [No Abstract] [Full Text] [Related]
5. Piperacetazine (Quide): a controlled evaluation of the elixir in chronic schizophrenic patients. Gallant DM; Bishop MP Curr Ther Res Clin Exp; 1970 Jun; 12(6):387-9. PubMed ID: 4987346 [No Abstract] [Full Text] [Related]
6. [Psychopharmacologic contribution to the clinical use of a psychosedative]. Pernhaupt G; Quatember R Wien Med Wochenschr; 1970 Oct; 120(42):737-40. PubMed ID: 4926115 [No Abstract] [Full Text] [Related]
7. Withdrawal of ataractic medication in schizophrenic patients. Garfield SL; Gershon S; Sletten I; Neubauer H; Ferrel E Dis Nerv Syst; 1966 May; 27(5):321-5. PubMed ID: 5327466 [No Abstract] [Full Text] [Related]
8. The effectiveness of combined phenothiazine and butyrophenone treatment in chronic schizophrenic patients. Lehmann HE; Ban TA; Lee H Curr Ther Res Clin Exp; 1967 Jan; 9(1):36-7. PubMed ID: 4963021 [No Abstract] [Full Text] [Related]
9. Piperacetazine in ambulatory chronic schizophrenic patients. Rada RT; Donlon PT Curr Ther Res Clin Exp; 1974 Feb; 16(2):124-9. PubMed ID: 4156665 [No Abstract] [Full Text] [Related]
10. An uncontrolled clinical study with piperacetazine in the maintenance treatment of chronic schizophrenic patients. Amin MM; Brahm E; Ban TA; Lehmann HE Psychopharmacol Bull; 1977 Jul; 13(3):10-1. PubMed ID: 18753 [No Abstract] [Full Text] [Related]
11. Carphenazine in the treatment of schizophrenic psychoses. Controlled clinical trial. Vinar O; Formánková M; Taussigová D; Růzicka S Act Nerv Super (Praha); 1967 Nov; 9(4):353-5. PubMed ID: 4889058 [No Abstract] [Full Text] [Related]
12. [Psychopharmacologic study of 8909 RP (Neuleptil) by Wittenborn's Psychiatric Status Rating Scale]. Beauseigneur-Nuyts T; Vallet R; Le Viet MQ Encephale; 1964; 53(3):405-14. PubMed ID: 4388707 [No Abstract] [Full Text] [Related]
13. Bupropion for depression in schizophrenia. Englisch S; Inta D; Eer A; Zink M Clin Neuropharmacol; 2010; 33(5):257-9. PubMed ID: 20852411 [TBL] [Abstract][Full Text] [Related]
14. Relative efficacy of butaperazine and chlorpromazine in acute schizophrenia. Gershon S; Hekimian LJ; Burdock EI; Park S; Floyd A Curr Ther Res Clin Exp; 1970 Dec; 12(12):810-8. PubMed ID: 4396420 [No Abstract] [Full Text] [Related]
15. [Comparative study of butaperazine and prochlorperazine for schizophrenia in acute phase]. Albert JM; Rajotte P; Rajotte E; Tétreault L Union Med Can; 1970 Jul; 99(7):1282-5. PubMed ID: 4396306 [No Abstract] [Full Text] [Related]
16. Evaluation of piperacetazine (Quide) injection in acute schizophrenics. Kiev A; Güclü B; Kulkarni AS Curr Ther Res Clin Exp; 1972 Jul; 14(7):376-80. PubMed ID: 4625517 [No Abstract] [Full Text] [Related]
17. Antidepressant treatment of depression in the recovering schizophrenic. Salamon I; Post J Dis Nerv Syst; 1966 Aug; 27(8):531-3. PubMed ID: 5947639 [No Abstract] [Full Text] [Related]
18. A trial of thioproperazine (Majeptil) in schizophrenia. Askar AM; el-Guindi T; Shaalan M; Gawad MS; Rakhawy YT J Egypt Med Assoc; 1968; 51(2):123-9. PubMed ID: 4386301 [No Abstract] [Full Text] [Related]
19. Early clinical drug evaluation units reports. Psychopharmacol Bull; 1972 Jan; 8(1):60-72. PubMed ID: 4554930 [No Abstract] [Full Text] [Related]
20. Schizophrenic subtypes defined by response to drugs and placebo. Goldberg SC; Mattsson NB Dis Nerv Syst; 1968 May; 29(5):Suppl:153-8. PubMed ID: 4876985 [No Abstract] [Full Text] [Related] [Next] [New Search]